Acne is a common reason for presentation in general practice. Yet, recognising when hormonal factors are driving the condition, or when hormonal therapy should be considered, is challenging.¹ As evidence supporting hormonal treatments for acne accumulates,²,³ GPs need a practical, evidence-based approach for managing acne.

In this webinar, dermatologist Dr Alex Coe, gynaecologist Dr Nasreen Shamas, and GP Dr Anita Muñoz integrate current evidence into a practical framework for managing hormonal acne in women. Through a longitudinal patient case, the panel discusses acne pathophysiology, first-line management, indications for combined oral contraceptives and spironolactone, counselling strategies, practical prescribing considerations, when to investigate for underlying disorders, or refer for specialist care.³⁻⁵

The webinar features an extensive live Q&A. Guided by a multidisciplinary panel, you will be exposed to challenging clinical scenarios and receive practical insights that can be applied in your practice.

Learning Outcomes

1. Apply current evidence when choosing appropriate acne management for women, including hormonal and non-hormonal options.
2. Review the evidence base and risk profile of hormonal acne treatment options - including combined oral contraceptives and spironolactone - to support shared decision-making.
3. Identify when to refer a patient with hormonal acne, including recognising signs that warrant further endocrine investigation.

This activity has Reviewing Performance and Measuring Outcomes activities available by clicking the RP and MO buttons above.

Provider

The Provider of this activity is Praxhub. Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com.

References:

1. Bagatin E, et al. An Bras Dermatol. 2019;94(1):62-75.
   2.Smith CA, et al. Dermatol Ther (Heidelb). 2025;15:45-59.
2. Therapeutic Guidelines. Dermatology. 2026.
3. RANZCOG. C-Gyn 3 Contraception (incorporating C-Gyn 3.12). 2024.
4. Therapeutic Guidelines. Sexual and Reproductive Health. 2026.